Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Schizophrenia

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.

Psychological and Sociocultural Causes of Schizophrenia

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...

Biological Causes of Schizophrenia

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...

Substance Use Disorders Affecting Sleep

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of cognitive impairment and depression on asthma in older patients.

The journal of allergy and clinical immunology. In practice·2026

Same author

The association between alcohol consumption and inflammatory biomarkers in a large, diverse, community-based sample.

Alcohol and alcoholism (Oxford, Oxfordshire)·2026

Same author

Highlights for the <i>Journal of Dual Diagnosis</i> from 2025.

Journal of dual diagnosis·2025

Same author

Toward the 2025 ACLP Annual Meeting: Advancing Consultation-Liaison Psychiatry Through Inspiration, Investigation, Innovation, and Implementation.

Journal of the Academy of Consultation-Liaison Psychiatry·2025

Same author

Correction: Evaluating psychiatry journals' adherence to informed consent guidelines for case reports.

Research integrity and peer review·2025

Same author

Evaluating psychiatry journals' adherence to informed consent guidelines for case reports.

Research integrity and peer review·2025

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Comorbid schizophrenia and substance abuse.

Alan I Green¹, E Sherwood Brown

¹Department of Psychiatry, Dartmouth Medical School, Hanover, NH, USA.

The Journal of Clinical Psychiatry

|November 4, 2006

Summary

Many individuals with schizophrenia develop substance use disorders, complicating treatment and worsening outcomes. This review covers the prevalence, neurobiology, and treatment of this common comorbidity.

Area of Science:

Neuroscience
Psychiatry
Addiction Medicine

Background:

Substance abuse is highly prevalent in patients with schizophrenia.
This comorbidity negatively impacts both short- and long-term patient outcomes.
Commonly abused substances include alcohol, cannabis, cocaine, and nicotine.

Purpose of the Study:

To describe the prevalence, outcomes, and underlying basis of substance abuse comorbidity in schizophrenia.
To explore the neurobiological factors contributing to substance abuse vulnerability in schizophrenia.
To review and weigh the efficacy of various treatment options for comorbid schizophrenia and substance use disorders.

Main Methods:

Literature review and synthesis of existing research on schizophrenia and substance abuse.

More Related Videos

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Related Experiment Videos

Last Updated: Jul 19, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Discussion of neurobiological mechanisms linking schizophrenia and reward system alterations.

Evaluation of pharmacological (antipsychotics, adjunctive agents) and psychosocial interventions.

Main Results:

Co-occurring substance use exacerbates schizophrenia symptoms and prognosis.
Schizophrenia's impact on the brain's reward system may predispose individuals to substance abuse.
Treatment efficacy varies, with combined pharmacological and psychosocial approaches often recommended.

Conclusions:

Addressing substance abuse is critical for improving schizophrenia patient care.
Understanding the neurobiology can inform targeted treatment strategies.
Further research is needed to optimize interventions for this complex comorbidity.